Health
International trial of blood thinners for COVID-19 treatment begins – News-Medical.Net
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new da…
A recent news release by the National Institutes of Health (NIH) announces the start of two Phase 3 clinical trials to explore blood thinners as treatments for COVID-19.
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new data on the safety and efficacy of these drugs in the treatment of activ…
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News22 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving
-
Noosa News23 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News16 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track